• About Rapidd™
  • Benefits
  • Services
• API
  • Toxicology & GMP Supply
  • Radiolabelling
  • Solid State Characterisation
• Analytical
  • Method Development & Validation
  • API & Drug Product Stability
• Drug Product
  • Formulation Development
  • Product Manufacture, Packaging, Labelling & Release
• Pre-Clinical Toxicology
• Regulatory

Would you like to save 12 months development time in early stage clinical development?

We understand the critical timelines in drug development and the key advantages our clients gain in significantly reducing development timelines through achieving milestones earlier, minimising cash-burn, quicker return on investment and gaining competitive advantage.

Rapidd™ offers a complete set of solutions aimed at accelerating entry into early stage clinical development. Rapidd™ is a lean, efficient, integrated solution from selection of pre-clinical candidate to Phase I regulatory submission.

Almac, in collaboration with a selection of preferred CROs, provides world class talent delivering a unique drug development package leading to completion of Phase I regulatory submission in under 12 months.